BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21219813)

  • 1. Usefulness of intravenous heparin to prevent thrombosis of central venous catheter in children.
    Bracho-Blanchet E; Cortés-Sauza J; Dávila-Pérez R; Lezama-Del Valle P; Villalobos-Alfaro C; Nieto-Zermeño J
    Cir Cir; 2010; 78(5):423-9. PubMed ID: 21219813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah PS; Shah VS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A continuous heparin infusion does not prevent catheter-related thrombosis in infants after cardiac surgery.
    Schroeder AR; Axelrod DM; Silverman NH; Rubesova E; Merkel E; Roth SJ
    Pediatr Crit Care Med; 2010 Jul; 11(4):489-95. PubMed ID: 20101197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial.
    Abdelkefi A; Ben Othman T; Kammoun L; Chelli M; Romdhane NB; Kriaa A; Ladeb S; Torjman L; Lakhal A; Achour W; Ben Hassen A; Hsaïri M; Ladeb F; Ben Abdeladhim A
    Thromb Haemost; 2004 Sep; 92(3):654-61. PubMed ID: 15351864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin infusion to prevent umbilical venous catheter related thrombosis in neonates.
    Unal S; Ekici F; Cetin İİ; Bilgin L
    Thromb Res; 2012 Nov; 130(5):725-8. PubMed ID: 22901699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
    Shah PS; Shah N
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005983. PubMed ID: 17943871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Continuous Low-Dose Heparin Infusion for Central Venous Catheter Patency in Critically Ill Children Worldwide.
    Onyeama SJ; Hanson SJ; Dasgupta M; Hoffmann RG; Faustino EV;
    Pediatr Crit Care Med; 2016 Aug; 17(8):e352-61. PubMed ID: 27362853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
    Handrup MM; Møller JK; Schrøder H
    Pediatr Blood Cancer; 2013 Aug; 60(8):1292-8. PubMed ID: 23417891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin-bonded central venous catheters on the incidence of catheter-related thrombosis and infection in children and adults.
    Long DA; Coulthard MG
    Anaesth Intensive Care; 2006 Aug; 34(4):481-4. PubMed ID: 16913346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis.
    Vidal E; Sharathkumar A; Glover J; Faustino EV
    J Thromb Haemost; 2014 Jul; 12(7):1096-109. PubMed ID: 24801495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.
    Schoot RA; van Ommen CH; Stijnen T; Tissing WJ; Michiels E; Abbink FC; Raphael MF; Heij HA; Lieverst JA; Spanjaard L; Zwaan CM; Caron HN; van de Wetering MD
    Eur J Cancer; 2015 Sep; 51(14):2031-8. PubMed ID: 26188849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation-associated complications of indwelling arterial and central venous catheters during heparin prophylaxis--a prospective study.
    Hentschel R; Wiescholek U; von Lengerke J; Harms E; Jorch G
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S126-9. PubMed ID: 10650851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
    Schallom ME; Prentice D; Sona C; Micek ST; Skrupky LP
    Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
    Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
    J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P; Mille D; Laporte S; Charlet V; Buchmüller-Cordier A; Jacquin JP; Fournel P; Dutrey-Dupagne C; Decousus H;
    Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.